Cargando…
PHI density prospectively improves prostate cancer detection
PURPOSE: To evaluate the Prostate Health Index (PHI) density (PHID) in direct comparison with PHI in a prospective large cohort. METHODS: PHID values were calculated from prostate-specific antigen (PSA), free PSA and [− 2]proPSA and prostate volume. The 1057 patients included 552 men with prostate c...
Autores principales: | Stephan, Carsten, Jung, Klaus, Lein, Michael, Rochow, Hannah, Friedersdorff, Frank, Maxeiner, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510982/ https://www.ncbi.nlm.nih.gov/pubmed/33471165 http://dx.doi.org/10.1007/s00345-020-03585-2 |
Ejemplares similares
-
The prostate health index PHI predicts oncological outcome and biochemical recurrence after radical prostatectomy - analysis in 437 patients
por: Maxeiner, Andreas, et al.
Publicado: (2017) -
Prostate volume and its influence on clinical parameters in prostate cancer detection
por: Stephan, Carsten, et al.
Publicado: (2023) -
Does the Prostate Health Index Depend on Tumor Volume?—A Study on 196 Patients after Radical Prostatectomy
por: Friedersdorff, Frank, et al.
Publicado: (2017) -
Artificial neural network (ANN) velocity better identifies benign prostatic hyperplasia but not prostate cancer compared with PSA velocity
por: Stephan, Carsten, et al.
Publicado: (2008) -
Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy
por: Stephan, Carsten, et al.
Publicado: (2022)